Traws Pharma, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Reddy E Premkumar | — | X | 133,000 | $4.10 | $545,300 | 266,784 | Jul 29, 2016 |
| Maniar Manoj | SVP - Product Development | Option Exercise | 50 | $6.50 | $325 | 50 | Jun 30, 2016 |
| GROOPMAN JEROME | — | Option Exercise | 10 | $5.20 | $52 | 10 | Jun 29, 2016 |
| MARINO JAMES J | — | Option Exercise | 10 | $5.20 | $52 | 10 | Jun 27, 2016 |
| Fruchtman Steven M | Chief Medical Officer | Option Exercise | 100 | $6.50 | $650 | 100 | Jun 24, 2016 |
| Baxter Healthcare SA | — | Other | 2,603,295 | — | — | — | May 6, 2015 |
| Hoffman Michael B | — | Option Exercise | 18,754 | $2.67 | $50,073 | 18,754 | Jul 7, 2014 |
| Reddy E Premkumar | — | Option Exercise | 27,084 | $1.33 | $36,022 | 1,337,838 | May 2, 2014 |
| Michael & Jane Hoffman 2013 Descendants | — | Purchase | 71,740 | $8.91 | $639,203 | 4,518,275 | Feb 20, 2014 |
| Hoffman Michael B | — | Purchase | 71,740 | $8.91 | $639,203 | 4,518,275 | Feb 20, 2014 |
| Kumar Ramesh | President and CEO | Option Exercise | 13,543 | $6.00 | $81,258 | 290,043 | Feb 10, 2014 |
| Kumar Ramesh | President and CEO | Sale | 20,000 | $15.07 | $301,400 | 276,500 | Jan 30, 2014 |
| Michael & Jane Hoffman 2013 Descendants | — | Purchase | 31,706 | $11.96 | $379,204 | 4,349,206 | Jan 27, 2014 |
| Hoffman Michael B | — | Purchase | 25,589 | $11.86 | $303,486 | 4,374,795 | Jan 24, 2014 |
| Reddy E Premkumar | — | Option Exercise | 32,036 | $1.33 | $42,608 | 1,310,754 | Dec 19, 2013 |
| Michael & Jane Hoffman 2013 Descendants | — | Purchase | 100 | $14.37 | $1,437 | 4,312,600 | Nov 22, 2013 |
| Hoffman Michael B | — | Purchase | 4,900 | $14.39 | $70,511 | 4,317,500 | Nov 22, 2013 |
| Hoffman Michael B | — | Purchase | 5,000 | $11.87 | $59,350 | 4,312,500 | Nov 18, 2013 |
| Michael & Jane Hoffman 2013 Descendants | — | Purchase | 5,000 | $11.87 | $59,350 | 4,312,500 | Nov 18, 2013 |
| Reddy E Premkumar | — | Purchase | 5,000 | $12.10 | $60,500 | 1,278,718 | Nov 18, 2013 |
| Hoffman Michael B | — | Purchase | 1,900 | $12.21 | $23,199 | 4,299,700 | Nov 15, 2013 |
| Michael & Jane Hoffman 2013 Descendants | — | Purchase | 7,800 | $11.97 | $93,366 | 4,307,500 | Nov 15, 2013 |
| Kumar Ramesh | President and CEO | Purchase | 1,100 | $12.02 | $13,222 | 276,500 | Nov 15, 2013 |
| Bienen Henry S | — | Purchase | 152 | $12.09 | $1,838 | 14,935 | Nov 15, 2013 |
| Altland James | SVP, Finance & Corp. Develop. | Option Exercise | 5,000 | $6.00 | $30,000 | 10,000 | Oct 10, 2013 |
| MEHTA VIREN | — | C | 73,839 | — | — | 85,479 | Jul 30, 2013 |
| Kumar Ramesh | President and CEO | C | 811 | — | — | 267,325 | Jul 30, 2013 |
| Michael & Jane Hoffman 2013 Descendants | — | C | 1,226,942 | — | — | 3,287,800 | Jul 30, 2013 |
| Hoffman Michael B | — | C | 84,530 | — | — | 1,746,953 | Jul 30, 2013 |
| Reddy E Premkumar | — | C | 19,569 | — | — | 1,221,117 | Jul 30, 2013 |
| Bienen Henry S | — | C | 6,868 | — | — | 6,868 | Jul 30, 2013 |
| Altland James | SVP, Finance & Corp. Develop. | Option Exercise | 5,000 | $6.00 | $30,000 | 5,000 | Jul 30, 2013 |
| MCKEARN THOMAS J | President, R&D | Purchase | 3,333 | $15.00 | $49,995 | 3,333 | Jul 30, 2013 |
| BANSAL AJAY | Chief Financial Officer | C | 23,785 | — | — | 43,846 | Jul 30, 2013 |
| Baxter Healthcare SA | — | C | 2,273,295 | — | — | 2,273,295 | Jul 30, 2013 |
| Reddy E Premkumar | — | Purchase | 700 | $22.73 | $15,911 | 1,273,718 | Jul 25, 2013 |